Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Cannabis

Cannabis

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

InMed Provides An Update On Phase 2 Clinical Trial Investigating Cannabinol Cream For Epidermolysis Bullosa

By Vuk Zdinjak
July 25, 9:13 AM
InMed Pharmaceuticals Inc. (NASDAQ: INM) provided an update on its phase 2 clinical trial using investigational drug INM-755 cannabinol (“CBN”) cream for the treatment

INM

Read More
2 minute read
  • Analyst Ratings
  • Cannabis
  • Markets
  • News
  • Penny Stocks

High Tide Faces ‘Tough Market Climate’ For Retail, Analyst Lowers Price Target On Cannabis Stock

By Nina Zdinjak
July 25, 8:26 AM
High Tide (NASDAQ: HITI) recently closed a $10 million deal equity financing deal.

HITI

Read More
1 minute read
  • Analyst Ratings
  • Cannabis
  • Downgrades
  • Markets
  • News
  • Price Target

Cantor Fitzgerald Downgrades Auxly Cannabis Group to Neutral, Lowers Price Target to C$0.08

By Benzinga Newsdesk
July 25, 5:57 AM
Cantor Fitzgerald analyst Pablo Zuanic downgrades Auxly Cannabis Group (TSX:XLY) from Overweight to Neutral and lowers the price target from C$0.2 to C$0.08.

TSX:XLY

Read More
1 minute read
  • Analyst Ratings
  • Cannabis
  • Downgrades
  • Markets
  • News
  • Price Target

Cantor Fitzgerald Downgrades Fire & Flower Holdings to Neutral, Lowers Price Target to C$2.6

By Benzinga Newsdesk
July 25, 5:48 AM
Cantor Fitzgerald analyst Pablo Zuanic downgrades Fire & Flower Holdings (TSX:FAF) from Overweight to Neutral and lowers the price target from C$9.5 to C$2.6.

TSX:FAF

Read More
3 minute read
  • Cannabis
  • Entrepreneurship
  • ESG
  • Events
  • Exclusives
  • General
  • Markets
  • News
  • Small Business
  • Startups
  • Success Stories

How To Align Medical Marijuana Strains With Specific Conditions: Learn From Dr. Chanda Macias, Scientist, Researcher And Cannabis Pioneer

By Maureen Meehan
July 24, 1:00 PM
Dr. Chanda Macias is a trailblazer in the legal cannabis industry many times over.

CL

Read More
6 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Small Cap

How To Get In Touch With The 5 Biggest Cannabis Operators In The US

By Nina Zdinjak
July 23, 1:14 PM
While there’s no doubt that the federal legalization of marijuana would make the industry explode, current trends shouldn’t be underestimated.

CCHWF

Read More
2 minute read
  • Cannabis
  • Markets

Arkansas: State-Licensed Medical Cannabis Businesses Sued By THC Levels Inflated?

By Joana Scopel
July 22, 7:48 PM
Three Arkansas residents have filed a federal lawsuit against four licensed medical marijuana companies operating in the state, accusing them of altering the THC levels on the labels of cannabis products they sell to medical cannabis users.

CSE:STPH

Read More
1 minute read
  • Cannabis
  • Markets
  • Movers

Cannabis Stock Movers For July 22, 2022

By Benzinga Insights
July 22, 5:45 PM
GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 31.25% at $0.02

ACB

Read More
1 minute read
  • Cannabis
  • Markets
  • Movers

Psychedelic Stock Gainers And Losers From July 22, 2022

By Benzinga Insights
July 22, 5:44 PM
GAINERS: Allied (OTC:ALID) shares closed up 11.04% at $0.50

ALID

Read More
2 minute read
  • Cannabis
  • Entrepreneurship
  • General
  • Markets
  • Movers & Shakers
  • News
  • Penny Stocks

Strategic Cannabis Execs Making Changes At Companies You Know: Curaleaf, Valens, Copperstate & Delic

By Jelena Martinovic
July 22, 12:49 PM
As Benzinga Cannabis Capital Conference returns (September 13-14) in Chicago, gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the latest leadership changes within the space.

CSE:DELC

Posts pagination

Previous 1 … 432 433 434 … 449 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service